Below I’ve listed some papers that are recommended for weekend reading. Enjoy. You can find more recent recommended reads here. Cool new heterochromatin stem cell aging paper in Science from Izpisua Belmonte Lab. ESC apoptosis pathway. An Apela RNA-Containing Negative Feedback Loop Regulates p53-Mediated Apoptosis in Embryonic Stem Cells, paper from Jing Huang lab in […]
Recommended stem cell papers for weekend reading Read More »
I invited the Chief Scientific Officer (CSO) of Bioheart, Kristin Comella, to do an interview after hearing some buzz that this could be a critical time for the company and that it might have been recently visited by the FDA. Note that Comella not just Bioheart CSO, but also the primary instructor for physician training in stem
Interview with Bioheart CSO, Kristin Comella including on FDA Read More »
It’s been exciting to watch the recent developments in using stem cells as the basis for treatments for Type I Diabetes. One of the major players in this arena is the privately-held company, ViaCyte. In this post, I interview ViaCyte President and CEO, Paul Laikind. The topics include their VC-01 product, the Encaptra device, an update on
ViaCyte CEO Laikind Interview: Trial Update, Melton, & Future Read More »
The pieces on my radar screen to read in my ample spare time as I work the weekend on literally 5 different grants include these pieces: NECSS and SfSBM: A weekend of science and skepticism Breaking Down Fat: Trends in adipose cell-based clinical trials PubPeer Selections: Odd citations, “practice makes perfect,” a Nature update Right Turn:
Recommended Weekend Science Reads Read More »
With the House of Lords vote yesterday, the UK officially became the only country in the world to have legalized human genetic modification via 3-Person IVF. The point of this “mitochondrial transfer” or “3-person IVF” technology is not directly to genetically modify humans specifically, but it still will lead to that result in any case.
UK OKs 3-Person IVF: Perspectives Read More »
There’s been some back and forth between me and some members of the UK Parliament and others in the UK on the issue of mitochondrial transfer or 3-person IVF technology. Some of this has involved the UK equivalent of the Surgeon General, Professor Dame Sally Davies, who at one point apparently called my views “bunk”. I
Red flags in Sally Davies letter on 3-person IVF mitochondrial transfer Read More »
What’s Cambrian Genomics? With rapid advances in genomics, gene editing, and methods to reproduce life in the lab such as cloning, today creating genetically modified organisms (GMOs) has never been easier. While there have been of course loads of discussions of GMOs in the past, we are entering a new era of what one might
Austen Heinz of Cambrian Genomics Interview: GMO creatures & people Read More »
Every year I do a list of top predictions for the coming year for the stem cell and regenerative medicine field. For example, you can see past top 10 predictions lists for 2013 and 2014. What’s in store for 2015 from the stem cell crystal ball? There is so much going on that for this
Stem Cell Predictions for 2015 Read More »
Cloning of animals is becoming a big, global business, and Hwang Woo-Suk is a major player here. Hwang Woo-Suk and animal cloning It turns out that this reproductive cloning of animals goes well beyond making duplicates of pets for sentimental customers at $100,000 a copy. Cloning of livestock by agribusinesses is becoming fairly common. Some
Cloning Factory in China Has Familiar Partner: Hwang Woo-Suk Read More »
With more than 4,142 votes cast, the readers of this blog have chosen the top 12 finalists for the Stem Cell Person of the Year Award for 2014 from the 27 nominees. You can see the final vote tallies at left. The votes came from more than 50 countries with some interesting geographic patterns (I
Diverse Stem Cell Person of the Year 2014 Award Finalists Read More »